CL King Downgrades SurModics (SRDX) as Cordis to Halt Manufacturing Cypher Stents
Tweet Send to a Friend
An analyst at CL King downgraded shares of SurModics (NASDAQ: SRDX) from Strong Buy to Buy. The firm reduced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


